<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-93193" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Endomyocardial Biopsy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmed</surname>
            <given-names>Talha</given-names>
          </name>
          <aff>University Of Maryland</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goyal</surname>
            <given-names>Amandeep</given-names>
          </name>
          <aff>University of Kansas Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Talha Ahmed declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amandeep Goyal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-93193.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The role and utility of endomyocardial biopsy (EMB) in the work-up of cardiovascular diseases remains controversial and the practice varies widely in different centers. EMB is a diagnostic modality used to evaluate various cardiac diseases in which non-invasive testing is usually not able to formulate a clinical diagnosis. This activity describes the background, indications, complications, and the technique required to perform an endomyocardial biopsy and highlights the role of the interprofessional team in the care of patients that undergo this procedure.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications and contraindications of endomyocardial biopsy.</p></list-item><list-item><p>Describe the equipment and technique in regards to endomyocardial biopsy.</p></list-item><list-item><p>Review the potential complications of endomyocardial biopsy.</p></list-item><list-item><p>Outline interprofessional team strategies for improving care coordination and communication to enhance the care of patients that undergo endomyocardial biopsy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=93193&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=93193">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-93193.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The role and utility of endomyocardial biopsy (EMB) in the work-up of cardiovascular diseases remains controversial, and the practice varies widely in different centers. EMB is a diagnostic modality used to evaluate various cardiac diseases in which non-invasive testing is usually not able to formulate a clinical diagnosis. Performing a biopsy is not without complications, and less invasive diagnostic procedures such as cardiac magnetic resonance imaging (MRI) or positron emission tomography (PET) scans outcompete EMB for certain indications. However,&#x000a0;there do exist certain conditions and scenarios in which doing an EMB is helpful in establishing the diagnosis when no other diagnostic test yields a substantial diagnosis. As with every diagnostic modality, the EMB procedure has unique characteristics in terms of sensitivity, specificity, and predictive values for different diseases. EMB is a multistep process consisting of deciding about indication, biopsy taking, sample handling, and interpretation. Apart from its clinical use, EMB also serves research purposes.<xref ref-type="bibr" rid="article-93193.r1">[1]</xref></p>
      </sec>
      <sec id="article-93193.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>EMB can be performed in the right or left ventricle. However, the most common location for biopsy sampling is within the right ventricular septum. Right ventricular access is commonly performed via the right or left femoral vein, or through the right internal jugular vein (the most common approach used in the United States). Left ventricular access is granted via the right or left femoral artery or the right radial artery.<xref ref-type="bibr" rid="article-93193.r1">[1]</xref></p>
        <p>Knowing the cardiac anatomy and the particular locations of localized involvement are important for proper sampling and reducing complications. For example, arrhythmogenic right ventricular dysplasia (ARVD) causes changes in the right ventricular free wall (which is especially prone to perforation during a biopsy) rather than the septum (which is the usual location of EMB sampling).&#x000a0;Cardiac masses, on a similar note, also have a distinct location within the heart, depending on its primary origin and character. For example, myxomas are most often found within the left atrium, whereas secondary neoplasms are often located in the right heart chambers. It has also been established that the expression of interstitial fibrosis and cardiac collagen type I is more reliably found when the EMB is performed in the left ventricle.<xref ref-type="bibr" rid="article-93193.r2">[2]</xref></p>
        <p>In order to decrease the sampling error in more diffuse processes, increasing the amount of EMBs taken has been established to decrease the sampling error.&#x000a0;When deciding between which ventricle to biopsy, utilization of cardiovascular magnetic resonance imaging (CMRI) and electrocardiogram concurrently during EMB has been shown to aid in guiding the physician to taking samples from areas of the heart that are shown to be actively affected by myocarditis or cardiac sarcoidosis.<xref ref-type="bibr" rid="article-93193.r3">[3]</xref></p>
      </sec>
      <sec id="article-93193.s4" sec-type="Indications">
        <title>Indications</title>
        <p>EMB is not a commonly indicated test in the diagnosis of heart disease. However, under some special clinical scenarios, EMB has a particular diagnostic and prognostic significance. There are no randomized clinical studies to prove the utility of EMB in any cardiac disease, and the recommendations are based on retrospective analysis, case series, and expert opinion.</p>
        <p>Broadly, EMB can be used to diagnose&#x000a0;heart failure of unknown etiology, cardiac sarcoidosis, amyloidosis, inflammatory cardiomyopathies, storage diseases (such as hemochromatosis), cardiac masses, and antineoplastic side effects. It can also be used&#x000a0;in the surveillance&#x000a0;of patients with a heart transplant or to&#x000a0;differentiate&#x000a0;between constrictive pericarditis and restrictive cardiomyopathy or right ventricular myocarditis and arrhythmogenic right ventricular cardiomyopathy.&#x000a0;</p>
        <p>
<bold>Diagnostic Indications</bold>
</p>
        <p>
<bold>Heart Failure of Unknown Etiology</bold>
</p>
        <p>A special role of EMB is in patients who develop acute decompensated heart failure (less than 2 weeks in duration). If other causes of heart failure are excluded, including coronary artery disease, obtaining an EMB has a unique prognostic significance. Fulminant lymphocytic myocarditis (FLM) has an excellent prognosis, while on the other hand, giant cell myocarditis (GCM) and necrotizing eosinophilic myocarditis (NEM) specify poor prognosis.</p>
        <p>This carries a clinical significance as patients with FLM have the probability of recovering on their own while those with GCM and NEM should be considered for immunosuppressive therapies as well as mechanical circulatory support if needed.</p>
        <p>Another recommendation to performing EMB is heart failure of 2 weeks to months in duration with dilated left ventricle and associated arrhythmias (high-grade heart blocks, ventricular arrhythmias) and failure to respond to usual care. The concern here is GCM, which has a poor prognosis and usually requires immunosuppression and heart transplant in certain cases.<xref ref-type="bibr" rid="article-93193.r4">[4]</xref></p>
        <p>
<bold>Cardiac Sarcoidosis</bold>
</p>
        <p>In cases of cardiac sarcoidosis, misdiagnosis of patients with other similar-presenting conditions, particularly idiopathic granulomatous myocarditis and GCM, is highly possible. However, due to its patchy involvement, the diagnostic yield of EMB is low (20% to 30%), even in patients with full-blown features of sarcoidosis. The use of cardiac magnetic resonance imaging to localize the areas of involvement may improve the diagnostic yield of biopsy.<xref ref-type="bibr" rid="article-93193.r5">[5]</xref><xref ref-type="bibr" rid="article-93193.r6">[6]</xref>&#x000a0;It is important to distinguish sarcoidosis from GCM as both have giant cells. The transplant-free survival at 1-year is much higher for sarcoidosis than for GCM. Also, patients with sarcoidosis usually respond to steroids, and an implantable cardioverter-defibrillator (ICD) can treat ventricular arrhythmias in&#x000a0;these patients.</p>
        <p>
<bold>Hypersensitivity Myocarditis</bold>
</p>
        <p>Hypersensitivity myocarditis (HSM) is an uncommon disorder with the most common presentation being a chronic dilated cardiomyopathy (DCM) though rapidly progressive and fatal CM may also be seen. Eosinophilic cardiomyopathy (ECM) is a type of HSM that is associated with hypereosinophilic syndrome. It typically presents as biventricular failure developing over the course of weeks to months. It may be idiopathic or associated with allergic reactions, parasite infections, or malignancies.</p>
        <p>Both HSM and ECM are important to recognize as treatment of the offending parasite, allergy, or avoidance of the allergens may treat the underlying CM. It also distinguishes these entities from other fatal cardiomyopathies (CM) like GCM and NEM.</p>
        <p>
<bold>Suspected Anthracycline Cardiomyopathy</bold>
</p>
        <p>Given its invasive nature, EMB in patients treated with chemotherapeutic agents (anthracycline) may be best suited for situations in which there is a question as to the cause of cardiac dysfunction, as well as in select cases in which ultimate administration of greater than the usual upper limit of an agent is believed to be desirable, and in clinical studies of chemotherapeutic-related toxicity of newer agents and regimens.</p>
        <p>
<bold>Heart Failure With a Restrictive Pattern</bold>
</p>
        <p>Restrictive cardiomyopathy (RCM) can be infiltrative, non-infiltrative, or could be due to storage diseases. Idiopathic restrictive CM is a unique form of RCM in which the etiology is uncertain with non-invasive diagnostic testing, but EMB may show mild myocyte hypertrophy with myofibrillary disarray&#x000a0;which helps to&#x000a0;formulate the diagnosis. Since RCM may mimic constrictive pericarditis clinically and hemodynamically, a cardiac computed tomogram (CT) or CMR should be pursued in uncertain cases. If a clear rim of calcification is identified surrounding the heart, then there is no indication for EMB. Similarly, in amyloidosis, apple-green birefringence of any misfolded amyloid protein when visualized under polarized microscopy after staining the specimen with congo red stain is virtually diagnostic.<xref ref-type="bibr" rid="article-93193.r7">[7]</xref><xref ref-type="bibr" rid="article-93193.r8">[8]</xref></p>
        <p>
<bold>Cardiac Tumors</bold>
</p>
        <p>In diagnosing cardiac tumors except for typical myxomas (as they have the potential to embolize from manipulation), EMB may be a reasonable choice. Though numerous tumors have been reported to have been diagnosed with EMB, lymphomas are the most commonly reported in the literature.</p>
        <p>
<bold>Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)</bold>
</p>
        <p>The role of EMB in ARVC is controversial as there is a concern for perforation of the already thinned out right ventricular wall. Some experts believe that non-invasive testing may be utilized, while others think that a fibrofatty replacement of myocardium on cardiac biopsy may provide certainty to the diagnosis. A reasonable approach is to&#x000a0;employ non-invasive tests as the first-line option, considering EMB for cases of diagnostic uncertainty. &#x000a0;</p>
        <p>
<bold>Heart Transplant</bold>
</p>
        <p>Another indication for EMB is heart transplantation. In patients who undergo heart transplants, routine surveillance EMBs within the first year of transplant is performed to detect any evidence of transplant rejection, which may require further management by appropriate titration and adjustments of immunosuppressants.<xref ref-type="bibr" rid="article-93193.r8">[8]</xref></p>
      </sec>
      <sec id="article-93193.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Since EMB is an invasive procedure, it has both absolute and relative contraindications. Absolute contraindications to EMB include valvular diseases such as vegetations or stenosis and vascular pathologies such as aneurysm and thrombosis. Atrial myxomas have high embolic potential and should not be routinely biopsied.&#x000a0;Relative contraindications include coagulopathy, the use of dual antiplatelet therapy, or therapeutic anticoagulants. In situations of contraindication, alternatives to endomyocardial biopsy are needed, which include tissue doppler echocardiography, scintigraphy, and cardiac magnetic resonance imaging (CMRI).</p>
      </sec>
      <sec id="article-93193.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>A bioptome is used to obtain a cardiac biopsy. The procedure can be performed under fluoroscopy (more commonly used) or echocardiography. Different bioptomes are now available, which are more flexible and finer than the early versions. Vascular access for&#x000a0;right or left&#x000a0;heart biopsy is achieved through venous (internal jugular or femoral vein) or arterial puncture (radial or femoral artery), respectively. The bioptome is advanced through a sheath that has been placed using the Seldinger technique.<xref ref-type="bibr" rid="article-93193.r9">[9]</xref></p>
      </sec>
      <sec id="article-93193.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>An interventional cardiologist with experience doing EMBs is required to minimize the risk of complications. Additionally, a skilled interprofessional team of nurses and technologists in the cardiac catheterization lab should be utilized. Interpreting cardiac tissue samples requires knowledge and experience. Cardiac pathologists&#x000a0;are specially trained pathologists and interpret histologic samples which&#x000a0;stem from EMB or autopsy.<xref ref-type="bibr" rid="article-93193.r10">[10]</xref></p>
      </sec>
      <sec id="article-93193.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>Guiding the bioptome can be done through fluoroscopy in the catheterization laboratory or via intracardiac or transthoracic/transesophageal echocardiography at the bedside.<xref ref-type="bibr" rid="article-93193.r11">[11]</xref>&#x000a0;Echocardiography guidance offers a comparable alternative to radiography in terms of complications and procedure time.&#x000a0;Besides anatomic orientation, specific targeting can be achieved with voltage-mapping and CMR, thus decreasing sampling error. Real-time CMR-guided EMB requires MR-conditional devices. Voltage mapping can be used to identify certain pathologic areas (i.e., scar) characterized by conduction changes. Preprocedural imaging to locate areas of interest can increase the success of EMB.<xref ref-type="bibr" rid="article-93193.r12">[12]</xref></p>
      </sec>
      <sec id="article-93193.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>Before an endomyocardial biopsy, the patient should have discontinued any anticoagulation therapy for 16 hours prior to the procedure, as well as for 12 hours post-procedure. The patient's INR (international normalized ratio) must also be less than 1.5 before the procedure. After the patient is provided with anesthesia and sedation, they should be put into a supine position with a 3-lead electrocardiogram (ECG), blood pressure cuff, and oxygen saturation monitoring.</p>
        <p>To reduce discomfort during the procedure, analgesia and sedation&#x000a0;are necessary.&#x000a0;The&#x000a0;biopsy procedure takes several minutes on average.&#x000a0;To reduce sampling error, several&#x000a0;tissue samples should be taken. The preparation of histologic samples begins&#x000a0;just after the biopsy sample is taken. The different tissue samples are stored in formaldehyde, glutaraldehyde, and liquid nitrogen for evaluation using light microscopy, electron microscopy, immunofluorescence, or viral nucleic acid studies.&#x000a0;For&#x000a0;histologic examination, the samples are stained using hematoxylin-eosin, Masson trichrome, Congo red for identifying amyloidosis, and Prussian blue to detect iron deposition.&#x000a0;The following characteristic changes are identified:<xref ref-type="bibr" rid="article-93193.r13">[13]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Inflammation (myocarditis)</p>
          </list-item>
          <list-item>
            <p>Myocyte hypertrophy and disarray (idiopathic restrictive cardiomyopathy)</p>
          </list-item>
          <list-item>
            <p>Myocyte degradation and necrosis (necrotizing myocarditis)</p>
          </list-item>
          <list-item>
            <p>Fibrosis (ischemic or non-ischemic insults)</p>
          </list-item>
          <list-item>
            <p>Fibrofatty infiltration (ARVC)</p>
          </list-item>
          <list-item>
            <p>Iron deposition (hemochromatosis)</p>
          </list-item>
          <list-item>
            <p>Amyloid deposition (amyloidosis)</p>
          </list-item>
          <list-item>
            <p>Vascular abnormalities (vasculitis)</p>
          </list-item>
          <list-item>
            <p>Artifacts (no clinical significance)</p>
          </list-item>
        </list>
        <p>To quantify the extent of inflammation, a severity index has been defined, which includes&#x000a0;the number of mononuclear cells (CD3, CD45, CD68) and HLA activation (HLA-ABC, HLA-DR). Frozen tissue samples are analyzed for viral nucleic acid using the polymerase chain reaction (PCR) technique to identify cardiotropic strains of enteroviruses (coxsackievirus and echovirus), parvovirus, adenovirus, and herpes simplex virus.<xref ref-type="bibr" rid="article-93193.r14">[14]</xref></p>
        <p>The International Society for Heart and Lung Transplantation (ISHLT) grading evaluates&#x000a0;cardiac transplant tissue samples for signs of inflammation and myocyte damage allowing classification of allograft rejection reaction and better interobserver agreement.<xref ref-type="bibr" rid="article-93193.r15">[15]</xref>&#x000a0;A unique phenomenon can be observed following transplantation. Quilty lesions are the dense accumulation of lymphocytes confined to the endocardium (Quilty A lesion) or spreading to the myocardium (Quilty B Lesion).<xref ref-type="bibr" rid="article-93193.r16">[16]</xref></p>
        <p>The procedure of EMB may influence microscopic findings and cause artifacts.&#x000a0;These include contraction bands, mitochondrial massing, sarcolemmal folding,&#x000a0;cell swelling, and membrane disruption with the displacement of glycogen and lipids.&#x000a0;Contraction bands can be produced artificially by biopsy taking, whereas in the postmortem study, it can reflect pathology.<xref ref-type="bibr" rid="article-93193.r17">[17]</xref></p>
      </sec>
      <sec id="article-93193.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Complications can be divided into acute and chronic. Dreaded acute complications include pneumothorax, arrhythmias, perforation, pericardial effusion, pericardial tamponade, fistulas, heart block, arterial puncture, pulmonary embolization, nerve block/injury, hematoma, arteriovenous fistula, deep vein thrombosis, and tricuspid valve injury. Tricuspid injury, in particular, can be seen in patients undergoing multiple EMB procedures for transplant surveillance. The majority of regurgitation is tolerable and does not often progress to requiring valve replacement. However, care should be taken to minimize tricuspid valve tissue sampling during biopsies in patients who are known to expect frequent EMB procedures. The overall complication rate and the number of inconclusive samples are rather low, with severe adverse events in less than 1% and minor incidents up to 6% of procedures.<xref ref-type="bibr" rid="article-93193.r18">[18]</xref></p>
        <p>Delayed complications include access site bleeding, damage to the tricuspid valve, pericardial tamponade, and deep venous thrombosis.</p>
        <p>The risks of EMB depend on the clinical state of the patient, the experience of the operator, and the availability of expertise in cardiac pathology. If a patient with an indication for EMB presents at a medical center where expertise in EMB and cardiac pathology is unavailable, transfer of the patient to a medical center with such experience should be seriously considered. Additionally, patients with cardiogenic shock or unstable ventricular arrhythmias may require the care of specialists for the management of heart failure, including ventricular assist device placement and potentially heart transplantation.<xref ref-type="bibr" rid="article-93193.r19">[19]</xref><xref ref-type="bibr" rid="article-93193.r20">[20]</xref></p>
      </sec>
      <sec id="article-93193.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The clinical significance of endomyocardial biopsy depends on two factors which are, role in diagnosis and implication for treatment.&#x000a0;EMB is relevant and applicable in selected clinical cases.&#x000a0;EMB is essential to diagnose the diverse disease processes underlying cardiomyopathy presenting as heart failure.&#x000a0;But sometimes, the therapeutic consequence of EMB is limited.<xref ref-type="bibr" rid="article-93193.r21">[21]</xref>&#x000a0;Regarding the interpretation of histologic changes, the difference between structure&#x000a0;and function should be remembered.<xref ref-type="bibr" rid="article-93193.r22">[22]</xref>&#x000a0;Histopathologic appearance&#x000a0;does not necessarily relate to symptoms.</p>
        <p>In certain cases, the use of additional methodologies besides light microscopy and staining such as electron&#x000a0;microscopy and immunohistochemistry, and molecular analysis is recommended. For example, in hemochromatosis and some other storage diseases, there is diffuse involvement of the heart, and simple light microscopy of EMB specimens may not be diagnostic. When the index of suspicion of these diseases is high as suggested by symptoms and results of other diagnostic testing, special staining techniques (to detect iron and other substances infiltrating the heart) and molecular analysis may help diagnose the underlying disease.&#x000a0;</p>
        <p>The role of EMB to diagnose pathologic entities is changing over the years.&#x000a0;The Dallas criteria have been discussed controversially since many patients that&#x000a0;do not fulfill the Dallas criteria have been finally diagnosed to have myocarditis.<xref ref-type="bibr" rid="article-93193.r23">[23]</xref>&#x000a0;Apart from myocarditis, EMB suffers from low sensitivity, which is 25% for lymphocytic myocarditis and 35% cardiac sarcoidosis.<xref ref-type="bibr" rid="article-93193.r24">[24]</xref>&#x000a0;The poor sensitivity but good specificity makes EMB the diagnostic modality of choice in specific diseases. Thus high pretest probability is required. In patients with low pretest probability, other tests to rule out pathology should be preferred. These may include scintigraphy (indium-111, gallium-67).<xref ref-type="bibr" rid="article-93193.r25">[25]</xref><xref ref-type="bibr" rid="article-93193.r26">[26]</xref>&#x000a0;The combination of CMR and EMB has synergistic value in the diagnosis of myocarditis.<xref ref-type="bibr" rid="article-93193.r27">[27]</xref></p>
      </sec>
      <sec id="article-93193.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional team should be involved in the care of patients that undergo EMB. This team includes interventional cardiologists, cardiac pathologists, radiologists, and cardiology nurses and technicians. Decision-making regarding EMB should balance the risk of this invasive procedure, its treatment implication, and its diagnostic power compared to other diagnostic methods.&#x000a0;EMB is one&#x000a0;part&#x000a0;of the evaluation of cardiac pathology. As histology illustrates&#x000a0;cellular appearance, science evolves with trying to take a more detailed look at the subcellular and molecular levels. The findings of the genetic basis of cardiac diseases led to the common pathway hypothesis of hypertrophic and dilated cardiomyopathy and long QT syndromes.<xref ref-type="bibr" rid="article-93193.r28">[28]</xref><xref ref-type="bibr" rid="article-93193.r29">[29]</xref></p>
      </sec>
      <sec id="article-93193.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=93193&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=93193">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/93193/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=93193">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-93193.s14">
        <title>References</title>
        <ref id="article-93193.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsch&#x000f6;pe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kherad</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schultheiss</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>How to perform an endomyocardial biopsy?</article-title>
            <source>Turk Kardiyol Dern Ars</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>43</volume>
            <issue>6</issue>
            <fpage>572</fpage>
            <page-range>572-5</page-range>
            <pub-id pub-id-type="pmid">26363754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liang</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Hebl</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>DeSimone</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Madhavan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nanda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kapa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maleszewski</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Reeder</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Asirvatham</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis.</article-title>
            <source>JACC Heart Fail</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>2</volume>
            <issue>5</issue>
            <fpage>466</fpage>
            <page-range>466-73</page-range>
            <pub-id pub-id-type="pmid">25194292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahrholdt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Goedecke</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meinhardt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Athanasiadis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vogelsberg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fritz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Klingel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kandolf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sechtem</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology.</article-title>
            <source>Circulation</source>
            <year>2004</year>
            <month>Mar</month>
            <day>16</day>
            <volume>109</volume>
            <issue>10</issue>
            <fpage>1250</fpage>
            <page-range>1250-8</page-range>
            <pub-id pub-id-type="pmid">14993139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parrillo</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Aretz</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Palacios</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fallon</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Block</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure. Endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis.</article-title>
            <source>Circulation</source>
            <year>1984</year>
            <month>Jan</month>
            <volume>69</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-101</page-range>
            <pub-id pub-id-type="pmid">6689651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kusano</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Satomi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of cardiac sarcoidosis.</article-title>
            <source>Heart</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>102</volume>
            <issue>3</issue>
            <fpage>184</fpage>
            <page-range>184-90</page-range>
            <pub-id pub-id-type="pmid">26643814</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sohn</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YJ</given-names>
              </name>
            </person-group>
            <article-title>Viewpoints in the diagnosis and treatment of cardiac sarcoidosis: Proposed modification of current guidelines.</article-title>
            <source>Clin Cardiol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>41</volume>
            <issue>10</issue>
            <fpage>1386</fpage>
            <page-range>1386-1394</page-range>
            <pub-id pub-id-type="pmid">30144116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YW</given-names>
              </name>
            </person-group>
            <article-title>Cardiac amyloidosis diagnosed by endomyocardial biopsy.</article-title>
            <source>Korean J Intern Med</source>
            <year>1988</year>
            <month>Jul</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>148</fpage>
            <page-range>148-53</page-range>
            <pub-id pub-id-type="pmid">3154193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmed</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Safdar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ramani</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>A Novel Case of Idiopathic Restrictive Cardiomyopathy.</article-title>
            <source>Cureus</source>
            <year>2020</year>
            <month>Mar</month>
            <day>08</day>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>e7212</fpage>
            <pub-id pub-id-type="pmid">32269890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Melvin</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Endomyocardial biopsy: its history, techniques and current indications.</article-title>
            <source>Can Med Assoc J</source>
            <year>1982</year>
            <month>Jun</month>
            <day>15</day>
            <volume>126</volume>
            <issue>12</issue>
            <fpage>1381</fpage>
            <page-range>1381-6</page-range>
            <pub-id pub-id-type="pmid">7044509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thiene</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Veinot</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baandrup</surname>
                <given-names>UT</given-names>
              </name>
              <name>
                <surname>Basso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bruneval</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Buja</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Butany</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>d'Amati</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>de Gouveia</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Fallon</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Fishbein</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Gallagher</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Kholova</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Leone</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>McManus</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Schoen</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Sheppard</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>van der Wal</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Winters</surname>
                <given-names>GL</given-names>
              </name>
              <collab>Association for European Cardiovascular Pathology and Society for Cardiovascular Pathology Task Force on Training in Cardiovascular Pathology</collab>
            </person-group>
            <article-title>AECVP and SCVP 2009 recommendations for training in cardiovascular pathology.</article-title>
            <source>Cardiovasc Pathol</source>
            <year>2010</year>
            <season>May-Jun</season>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>129</fpage>
            <page-range>129-35</page-range>
            <pub-id pub-id-type="pmid">20071198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuppahally</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Litwin</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Michaels</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Endomyocardial biopsy of right atrial angiosarcoma guided by intracardiac echocardiography.</article-title>
            <source>Cardiol Res Pract</source>
            <year>2010</year>
            <volume>2010</volume>
            <fpage>681726</fpage>
            <pub-id pub-id-type="pmid">20585357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaidya</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Abudan</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Vasudevan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shantha</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Kapa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Noseworthy</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Asirvatham</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Deshmukh</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>The efficacy and safety of electroanatomic mapping-guided endomyocardial biopsy: a systematic review.</article-title>
            <source>J Interv Card Electrophysiol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>53</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-71</page-range>
            <pub-id pub-id-type="pmid">30003460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bedanova</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Necas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Petrikovits</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pokorny</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kovalova</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ondrasek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cerny</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Echo-guided endomyocardial biopsy in heart transplant recipients.</article-title>
            <source>Transpl Int</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>17</volume>
            <issue>10</issue>
            <fpage>622</fpage>
            <page-range>622-5</page-range>
            <pub-id pub-id-type="pmid">15502940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Caruso</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Myocardial disarray. A critical review.</article-title>
            <source>Br Heart J</source>
            <year>1982</year>
            <month>Jun</month>
            <volume>47</volume>
            <issue>6</issue>
            <fpage>527</fpage>
            <page-range>527-38</page-range>
            <pub-id pub-id-type="pmid">7044398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marc-Alexander</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Christoph</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Andreas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Joerg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bernward</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Michele</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Predictors of long-term outcome in patients with biopsy proven inflammatory cardiomyopathy.</article-title>
            <source>J Geriatr Cardiol</source>
            <year>2018</year>
            <month>May</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>363</fpage>
            <page-range>363-371</page-range>
            <pub-id pub-id-type="pmid">30083189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Calabrese</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carturan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thiene</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease.</article-title>
            <source>Heart Fail Rev</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>673</fpage>
            <page-range>673-81</page-range>
            <pub-id pub-id-type="pmid">23096264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adomian</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Laks</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Billingham</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>The incidence and significance of contraction bands in endomyocardial biopsies from normal human hearts.</article-title>
            <source>Am Heart J</source>
            <year>1978</year>
            <month>Mar</month>
            <volume>95</volume>
            <issue>3</issue>
            <fpage>348</fpage>
            <page-range>348-51</page-range>
            <pub-id pub-id-type="pmid">622977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sandhu</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Uretsky</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Zerbe</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Goldsmith</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Kormos</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Hardesty</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Coronary artery fistula in the heart transplant patient. A potential complication of endomyocardial biopsy.</article-title>
            <source>Circulation</source>
            <year>1989</year>
            <month>Feb</month>
            <volume>79</volume>
            <issue>2</issue>
            <fpage>350</fpage>
            <page-range>350-6</page-range>
            <pub-id pub-id-type="pmid">2644055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yilmaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kindermann</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kindermann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mahfoud</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ukena</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Athanasiadis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mahrholdt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Voehringer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schieber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Klingel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kandolf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>B&#x000f6;hm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sechtem</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance.</article-title>
            <source>Circulation</source>
            <year>2010</year>
            <month>Aug</month>
            <day>31</day>
            <volume>122</volume>
            <issue>9</issue>
            <fpage>900</fpage>
            <page-range>900-9</page-range>
            <pub-id pub-id-type="pmid">20713901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huddleston</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Rosenbloom</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Pasque</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Biopsy-induced tricuspid regurgitation after cardiac transplantation.</article-title>
            <source>Ann Thorac Surg</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>832</fpage>
            <page-range>832-6; discussion 836-7</page-range>
            <pub-id pub-id-type="pmid">8166527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grogan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Redfield</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Reeder</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Gersh</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Rodeheffer</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>80</fpage>
            <page-range>80-4</page-range>
            <pub-id pub-id-type="pmid">7797779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bortone</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Chiddo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gaglione</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Locuratolo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Caruso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rizzon</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Functional and structural abnormalities in patients with dilated cardiomyopathy.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1989</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>613</fpage>
            <page-range>613-23</page-range>
            <pub-id pub-id-type="pmid">2768711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeserich</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Konstantinides</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pavlik</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bode</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Geibel</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Non-invasive imaging in the diagnosis of acute viral myocarditis.</article-title>
            <source>Clin Res Cardiol</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>98</volume>
            <issue>12</issue>
            <fpage>753</fpage>
            <page-range>753-63</page-range>
            <pub-id pub-id-type="pmid">19756815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Tazelaar</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>LT</given-names>
              </name>
            </person-group>
            <article-title>The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis.</article-title>
            <source>J Card Fail</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>74</fpage>
            <page-range>74-8</page-range>
            <pub-id pub-id-type="pmid">12016630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yasuda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Palacios</surname>
                <given-names>IF</given-names>
              </name>
              <name>
                <surname>Dec</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Fallon</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Leinbach</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Khaw</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Haber</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis.</article-title>
            <source>Circulation</source>
            <year>1987</year>
            <month>Aug</month>
            <volume>76</volume>
            <issue>2</issue>
            <fpage>306</fpage>
            <page-range>306-11</page-range>
            <pub-id pub-id-type="pmid">3608120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camargo</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Mazzieri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Snitcowsky</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Higuchi</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Meneghetti</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Soares J&#x000fa;nior</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fiorelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ebaid</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pileggi</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Correlation between gallium-67 imaging and endomyocardial biopsy in children with severe dilated cardiomyopathy.</article-title>
            <source>Int J Cardiol</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>293</fpage>
            <page-range>293-7</page-range>
            <pub-id pub-id-type="pmid">2210893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biesbroek</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Beek</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Germans</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Niessen</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>van Rossum</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of myocarditis: Current state and future perspectives.</article-title>
            <source>Int J Cardiol</source>
            <year>2015</year>
            <month>Jul</month>
            <day>15</day>
            <volume>191</volume>
            <fpage>211</fpage>
            <page-range>211-9</page-range>
            <pub-id pub-id-type="pmid">25974197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bowles</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Bowles</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Towbin</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy.</article-title>
            <source>Herz</source>
            <year>2000</year>
            <month>May</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>168</fpage>
            <page-range>168-75</page-range>
            <pub-id pub-id-type="pmid">10904835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-93193.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Towbin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bowles</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <article-title>The failing heart.</article-title>
            <source>Nature</source>
            <year>2002</year>
            <month>Jan</month>
            <day>10</day>
            <volume>415</volume>
            <issue>6868</issue>
            <fpage>227</fpage>
            <page-range>227-33</page-range>
            <pub-id pub-id-type="pmid">11805847</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
